Immunome, Inc.
Clinical trials sponsored by Immunome, Inc., explained in plain language.
-
New radioactive drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called 177Lu-IM-3050 in about 105 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check the drug's safety and find the best dose. The drug delivers radiation directly to cancer cells to …
Phase: EARLY_PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for advanced cancers: experimental drug IM-1021 enters human testing
Disease control Recruiting nowThis early-stage study tests a new drug called IM-1021 in people with advanced solid tumors or certain blood cancers (lymphomas) that have not responded to other treatments. The main goals are to check the drug's safety and find the best dose. About 117 adults will take part in t…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated May 18, 2026 12:03 UTC